Who the current listings are forDogs
Cancer types currently listedHemangiosarcoma, Lymphoma, Oral Melanoma, Osteosarcoma
Participating Ethos hospitals
Open a hospital to see its current options and location.
CASE
Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
- Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
- Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Official study / enrollment information →
Colorado Animal Specialty & Emergency (CASE)
Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
Investigational oral treatment for newly diagnosed canine B-cell lymphoma
Ethos Veterinary Health · USA
Now enrolling
What is being offered: Newly diagnosed, treatment-naïve B-cell lymphoma; >1 year; 22–100 lb.
Who may qualify: Confirmed cancer diagnosis required; Min age years: 1; Min weight lb: 22; Max weight lb: 100; Active tumor required
May not qualify if: Prior immunotherapy
Costs / coverage: 🟢 Fully funded. All study-related visits are covered at no cost to the pet owner.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Overland Park Veterinary Emergency & Specialty, 8301 W 163rd St, Overland Park, KS 66223
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
First Coast Veterinary Specialists & Emergency
First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
- Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
- Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Official study / enrollment information →
Gulf Coast Veterinary Specialists
Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
MIMIC — minimally invasive metastasectomy for osteosarcoma lung metastases
Ethos Discovery / specialty-hospital network · USA
Open / currently enrolling
What is being offered: Thoracoscopic minimally invasive surgical removal of pulmonary metastatic nodules
Who may qualify: Confirmed cancer diagnosis required; Metastatic; Min weight lb: 11
Costs / coverage: 🟡 Partially funded. Study procedures are subsidized and provided at reduced cost; confirm the current owner contribution with the enrolling hospital.
Contact: Ethos Discovery enrollment request through official MIMIC study page
Participating locations
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
Official study / enrollment information →
Massachusetts Veterinary Referral Hospital
Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
- Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
- Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Official study / enrollment information →
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
Metropolitan Veterinary Hospital
Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Gilvetmab treatment study for canine malignant melanoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Safety and efficacy study of gilvetmab in dogs with malignant melanoma; age ≥1 year.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 6.6; Active tumor required; Min age years: 1
Costs / coverage: 🟢 Fully funded. All study-related visits are covered at no cost to the pet owner.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
- Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
- Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Official study / enrollment information →
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
Mission Veterinary Emergency & Specialty
Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
- Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
- Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Official study / enrollment information →
Overland Park Veterinary Emergency & Specialty
Overland Park Veterinary Emergency & Specialty, 8301 W 163rd St, Overland Park, KS 66223
Investigational oral treatment for newly diagnosed canine B-cell lymphoma
Ethos Veterinary Health · USA
Now enrolling
What is being offered: Newly diagnosed, treatment-naïve B-cell lymphoma; >1 year; 22–100 lb.
Who may qualify: Confirmed cancer diagnosis required; Min age years: 1; Min weight lb: 22; Max weight lb: 100; Active tumor required
May not qualify if: Prior immunotherapy
Costs / coverage: 🟢 Fully funded. All study-related visits are covered at no cost to the pet owner.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Overland Park Veterinary Emergency & Specialty, 8301 W 163rd St, Overland Park, KS 66223
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Peak Veterinary Referral Center
Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
- Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
- Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Official study / enrollment information →
Pet Emergency and Specialty Center of Marin
Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
SAGE – San Francisco
SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
Southeast Veterinary Oncology & Internal Medicine
Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
- Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
- Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Official study / enrollment information →
Summit Veterinary Referral Center
Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
Gilvetmab treatment study for canine malignant melanoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Safety and efficacy study of gilvetmab in dogs with malignant melanoma; age ≥1 year.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 6.6; Active tumor required; Min age years: 1
Costs / coverage: 🟢 Fully funded. All study-related visits are covered at no cost to the pet owner.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
Veterinary Emergency + Referral Center
Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
Veterinary Specialty Hospital
Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Gilvetmab treatment study for canine malignant melanoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Safety and efficacy study of gilvetmab in dogs with malignant melanoma; age ≥1 year.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 6.6; Active tumor required; Min age years: 1
Costs / coverage: 🟢 Fully funded. All study-related visits are covered at no cost to the pet owner.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Veterinary Specialty Hospital – North County
Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Novel vaccine versus carboplatin after amputation for canine appendicular osteosarcoma
Ethos Veterinary Health · USA
Now enrolling patients
What is being offered: Appendicular OSA; age >=1 year, >=44 lb, otherwise in good general health; cytologic/histologic confirmation. Current Ethos owner page lists 9 enrolling hospitals. An older AVMA registry listing contains additional historical sites; those are not promoted without current site-level confirmation.
Who may qualify: Confirmed cancer diagnosis required; Min weight lb: 44; Active tumor required; Appendicular location; Min age years: 1; Planned amputation
Costs / coverage: 🟡 Partially funded. All study-related visits are covered, including up to $4,000 toward amputation.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- First Coast Veterinary Specialists & Emergency, 301 Jacksonville Dr, Jacksonville Beach, FL 32250
- Metropolitan Veterinary Hospital, 734 Alpha Dr, Highland Heights, OH 44143
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Mission Veterinary Emergency & Specialty, 5914 Johnson Dr, Mission, KS 66202
- Peak Veterinary Referral Center, 158 Hurricane Ln, Williston, VT 05495
- Southeast Veterinary Oncology & Internal Medicine, 304 Corporate Way, Orange Park, FL 32073
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
Official study / enrollment information →
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
MIMIC — minimally invasive metastasectomy for osteosarcoma lung metastases
Ethos Discovery / specialty-hospital network · USA
Open / currently enrolling
What is being offered: Thoracoscopic minimally invasive surgical removal of pulmonary metastatic nodules
Who may qualify: Confirmed cancer diagnosis required; Metastatic; Min weight lb: 11
Costs / coverage: 🟡 Partially funded. Study procedures are subsidized and provided at reduced cost; confirm the current owner contribution with the enrolling hospital.
Contact: Ethos Discovery enrollment request through official MIMIC study page
Participating locations
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
Official study / enrollment information →
Veterinary Specialty Hospital – Sorrento Valley
Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Investigational oral treatment for newly diagnosed canine B-cell lymphoma
Ethos Veterinary Health · USA
Now enrolling
What is being offered: Newly diagnosed, treatment-naïve B-cell lymphoma; >1 year; 22–100 lb.
Who may qualify: Confirmed cancer diagnosis required; Min age years: 1; Min weight lb: 22; Max weight lb: 100; Active tumor required
May not qualify if: Prior immunotherapy
Costs / coverage: 🟢 Fully funded. All study-related visits are covered at no cost to the pet owner.
Contact: Contact participating Ethos hospital through official study page.
Participating locations
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Overland Park Veterinary Emergency & Specialty, 8301 W 163rd St, Overland Park, KS 66223
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
Official study / enrollment information →
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
WVRC – Grafton
WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
WVRC – Racine/Kenosha
WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
WVRC – Waukesha
WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
Ethos-PUSH precision-medicine umbrella study for splenic hemangiosarcoma
Ethos Discovery / multicenter specialty hospitals · USA
Open / currently enrolling
What is being offered: Phase 1 splenectomy/hemoabdomen study; dogs confirmed with non-metastatic splenic HSA can continue to fully funded active-treatment Phase 2, with treatment assigned among doxorubicin, doxorubicin+rapamycin, doxorubicin+sorafenib, or oral paclitaxel regimens.
Who may qualify: No metastasis; Active tumor required; Splenic primary; Planned surgery; Pre splenectomy; Min weight kg exclusive: 5; Max weight kg exclusive: 45
Costs / coverage: 🟡 Partially funded overall. Phase 1 provides $1,000 toward splenectomy; owners remain responsible for other initial surgical/screening costs. Dogs subsequently confirmed with splenic HSA and no metastases can enter fully funded Phase 2 (> $10,000 value). Sponsor states up to $3,000 for study-related side effects.
Contact: Ethos Discovery enrollment form / participating hospital; CASE: 303-545-2273
Participating locations
- Massachusetts Veterinary Referral Hospital, 20 Cabot Rd, Woburn, MA 01801
- Pet Emergency and Specialty Center of Marin, 901 Francisco Blvd E, San Rafael, CA 94901
- Veterinary Specialty Hospital - North County, 2055 Montiel Rd, San Marcos, CA 92069
- Veterinary Specialty Hospital, 10435 Sorrento Valley Rd, San Diego, CA 92121
- Veterinary Emergency + Referral Center of Hawaii, 345 N Nimitz Highway, Unit C, Honolulu, HI 96817
- WVRC Grafton, 1381 Port Washington Rd, Grafton, WI 53024
- WVRC Racine/Kenosha, 1123 58th Ave, Somers, WI 53144
- WVRC Waukesha, W239 N1046 Pewaukee Rd, Waukesha, WI 53188
- SAGE Veterinary Centers, 600 Alabama St, San Francisco, CA 94110
- Summit Veterinary Referral Center, 2505 S 80th St, Tacoma, WA 98409
- Colorado Animal Specialty & Emergency, 2972 Iris Ave, Boulder, CO 80301
- Gulf Coast Veterinary Specialists, 8042 Katy Fwy, Houston, TX 77024
- Metropolitan Veterinary Hospital, 1053 S Cleveland-Massillon Rd, Akron, OH 44321
Official study / enrollment information →
Free to use. No registration or paid report.
